CAS: 147059-75-4; Rel-7-((1R,5S,6S)-6-Amino-3-Azabicyclo[3.1.0]Hexan-3-yl)-1-(2,4-Difluorophenyl)-6-Fluoro-4-Oxo-1,4-Dihydro-1,8-Naphthyridine-3-Carboxylic Acid Compound With Methanesulfonic Acid (1:1)

该化合物是一种合成的氟丙酮抗生素,其抗药性范围广泛,针对的有抗格鲁阳性,克格鲁阴性,厌氧细菌,其中聚盐形式提高了溶性,提高了生物利用率和配方稳定性;该化合物显示出对细菌DNAGyrase和Topo异构体4的强烈抑制作用,干扰了DNA复制和转录;Trovafloxin meylate表现出了极好的组织渗透和延长半衰期,使得能够进行有效的剂量疗程;特别是,该物质在呼吸道和腹部病原体方面的活动受到限制,但是其临床用途因潜在的肝毒性而受到限制,需要仔细的风险-效益评估;该化合物对于研究氟五醇机制和抗药性模式的研究仍然很有价值.

结构式图片

欧盟法规

C&L通报

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-2024197774-A1
    优先权日:2021-04-16
    标 题:Synthesis of Antimicrobial PVP-coated Bismuth Nanoparticles
    发明人:LOPEZ-RIBOT JOSE; VAZQUEZ-MUNOZ ROBERTO
    权利人:UNIV TEXAS
    摘要:Described herein is a facile, fast, and economical method for the synthesis of BAL-mediated PVP-BiNPs, using basic laboratory instruments and reagents readily available in most laboratories.

    专利号:US-8557979-B2
    优先权日:2004-06-10
    标题 :Carbapenem antibacterials with gram-negative activity and processes for their preparation
    发明人:CHOI WOO-BAEG; KOWALIK EWA
    权利人:CHOI WOO-BAEG; KOWALIK EWA; FOB SYNTHESIS INC
    摘要:The present invention provides β-methyl carbapenem compounds and pharmaceutical compositions useful in the treatment of bacterial infections and methods for treating such infections using such compounds and/or compositions. The invention includes administering an effective amount of a carbapenem compound or salt and/or prodrug thereof to a host in need of such a treatment. The present invention is also in the field of synthetic organic chemistry and is specifically provides an improved method of synthesis of β-methyl carbapenems which are useful as antibacterial agents.

    专利号:US-10933051-B2
    优先权日:2017-06-09
    标 题 :Carbapenem compounds and compositions for the treatment of bacterial infections
    发明人:CHOI WOO-BAEG; TOMIOKA TAKASHI; JOO HYUNG-YEUL; TRUONG PHONG; MIN BRIAN
    权利人:FOB SYNTHESIS INC
    摘要:The present invention provides carbapenem compounds and pharmaceutical compositions useful in the treatment of bacterial infections, including drug resistant or multiple-drug resistant bacterial infections, and methods for treating such infections using such compounds and/or compositions. The invention includes administering an effective amount of a carbapenem compound or salt and/or prodrug thereof to a host in need of such a treatment.

    专利号:US-9937151-B2
    优先权日:2010-06-18
    标题 :Carbapenem antibacterials with gram-negative activity
    发明人:CHOI WOO-BAEG; GRUSZECKA-KOWALIK EWA; JOO HYUNG-YEUL; LIU SHUANGPEI; MAO SHULI; LI YONGFENG; KIM DEOG-IL
    权利人:FOB SYNTHESIS INC
    摘要:The present invention provides β-methyl carbapenem compounds and pharmaceutical compositions useful in the treatment of bacterial infections and methods for treating such infections using such compounds and/or compositions. The invention includes administering an effective amount of a carbapenem compound or salt and/or prodrug thereof to a host in need of such a treatment.

    专利号:WO-2022221748-A1
    优先权日:2021-04-16
    标题 :Synthesis of antimicrobial pvp-coated bismuth nanoparticles

    专利号:US-7547436-B2
    优先权日:1995-01-17
    标 题:Receptor specific transepithelial transport of therapeutics
    发明人:BLUMBERG RICHARD S; LENCER WAYNE I; SIMISTER NEIL E
    权利人:BRIGHAM & WOMENS HOSPITAL; UNIV BRANDEIS
    摘要:The present invention relates in general to methods and products for initiating an immune response against an antigen, and in particular relates to transepithelial delivery of antigens to provoke tolerance and immunity. The present invention further relates to methods and products for the transepithelial delivery of therapeutics. In particular, the invention relates to methods and compositions for the delivery of therapeutics conjugated to a FcRn binding partner to intestinal epithelium, mucosal epithelium and epithelium of the lung. The present invention further relates to the synthesis, preparation and use of the FcRn binding partner conjugates as, or in, pharmaceutical compositions for oral systemic delivery of drugs and vaccines.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Shaw PJ, Ganey PE, Roth RA. Idiosyncratic drug-induced liver injury and the role of inflammatory stress with an emphasis on an animal model of trovafloxacin hepatotoxicity. Toxicol Sci. 2010 Nov;118(1):7-18. doi: 10.1093/toxsci/kfq168. Epub 2010 Jun 10. Review.
    2: Mandell LA. [The role of trovafloxacin in the treatment of nosocomial pneumonia]. Medicina (B Aires). 1999;59 Suppl
    1:39-46. Review. Spanish. Review. Spanish. Review. Spanish. Review. Spanish. Review. Review. Review. Review. Review. Review. Review. Review.

    合成参考文献


    摘要:Archives of Internal Medicine., 159(2225), 1999
    参考文献:10.2165/00003495-199600522-00006
    摘要:Naber KG. Fluoroquinolones in urinary tract infections. Proper and improper use. Drugs. 1996;52 Suppl 2():27–33. doi: 10.2165/00003495-199600522-00006.
    参考文献:10.2165/00003495-199600522-00009
    摘要:Klugman KP. Epidemiology, control and treatment of multiresistant pneumococci. Drugs. 1996;52 Suppl 2():42–6. doi: 10.2165/00003495-199600522-00009.
    参考文献:10.2165/00003495-199957060-00002
    摘要:Momméja-Marin H, Carbon C. What is the place of fluoroquinolones in the treatment of community-acquired respiratory tract infections Drugs. 1999 Jun;57(6):851–3. doi: 10.2165/00003495-199957060-00002.
    参考文献:10.1007/s101560200000
    摘要:Niki Y. Pharmacokinetics and safety assessment of tosufloxacin tosilate. J Infect Chemother. 2002 Mar;8(1):1–18. doi: 10.1007/s101560200000.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知